Dabigatran etexilate Terminated Phase 2 Trials for Heart Valve Prosthesis / Thromboembolism Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01505881Follow on Study From RE-ALIGN